Healthtech startup PharmEasy raises ₹363 crores in series C led by Eight Roads Ventures

Must Read

Jharkhand polls for 81 constituencies from November 30 to December 20; counting on 23rd December

Addressing a press meeting today, Chief Election Commissioner Sunil Arora has announced the poll dates for Jharkhand Legislative assembly....

Congress forms six-member committee of AICC to review situation of NRC in Assam

In a bid to review the condition of Assam state after the implementation of the NRC exercise, Congress party...

Shiv Sena elects Eknath Shinde as party’s legislative leader; Sunil Prabhu appointed as chief whip of party

In a striking breakthrough, Shiv Sena elected senior minister Eknath Shinde as the party's legislative leader today. It has...

Mumbai-based online pharmacy startup PharmEasy has raised around ₹363 crores in series C round led by Eight Roads Ventures India, the proprietary investment arm of Fidelity International Limited (FIL), F-Prime Capital, Fundamentum Advisors, an investment firm backed by Nandan Nilekani and Sanjeev Aggarwal, and San Francisco-based hedge fund Think Investments.

It was earlier reported in July, that PharmEasy was expected to raise around $50 million. Also, the online pharmacy raised ₹40 crores in debt financing from InnoVen Capital, only a few weeks back.

Freshly infused funds will be used to set up technology team in Mumbai and Bengaluru, as it looks to scale both the cities and boosts technology capabilities.

PharmEasy was founded by Dharmil Seth and Dhaval Shah in 2015. It provides a technology platform to offer various healthcare services like medicine delivery, medicine refills & reminders, along with teleconsultation. It further integrates diagnostics centres, in order to help provide a comprehensive medical solution to its clients.

Talking about the investment, Dhaval Seth, Co-Founder, PharmEasy, said, “This round of funding reflects the confidence investors have in us and in our ability to change the face of healthcare in the country. This infusion will be utilised to build a larger consumer base, work towards improving our technology base, and put the company on a rapid growth trajectory without compromising on the superlative consumer experience that we have been known for always.”

PharmEasy operates a full stack model, procuring medicines directly from manufacturers and delivers it directly to customers. Within three years, the startup has a presence across more than 1,000 cities, covering over 22,000 pin codes in India. It also claims to receive around 8,000 orders a day.

Other players in the healthtech segment competing with PharmEasy include 1mg, MedPlus, NetMeds, Portea, Zoctr, Lybrate, and Tricog, among many others.

According to a May 2018 report titled “India E Pharmacy Market Opportunity Outlook 2024”, the ePharmacy market potential is worth over $1 billion with more than 30 startups assisting the growth of this segment in various regions of the country.

Indian ePharma market is expected to grow at a CAGR of over 20% to cross the mark of  $3 billion by 2024. There is an opportunity for growth in the healthcare segment overall, making it a lucrative industry for budding startups.

It is also to be noted that the overall Indian healthcare industry is expected to touch $280 billion by 2020, from current $100 billion, according to an IBEF report.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

Opposition again targets Goa CM over Mhadei issue (lead)

Panaji, Nov 15 (IANS) The Opposition in Goa on Friday accused Chief Minister Pramod Sawant of not defending Goa's...

Food, tea to cost more in Rajdhani, Shatabdi, Duranto trains

New Delhi, Nov 15 (IANS) The railway board has decided to increase the price of meals onboard Rajdhani, Shatabdi and Duronto express trains, which...

Oct merchandise exports down, imports fall over 16% YoY (Lead)

New Delhi, Nov 15 (IANS) Global slowdown amidst weak domestic demand dipped India's merchandise exports as well as imports in October on a year-on-year...

IBC norms for corporate debtors’ guarantors from Dec 1

New Delhi, Nov 15 (IANS) In a bid to boost the bankruptcy and insolvency mechanism, the government on Friday said the insolvency regime and...

Tickets for first 3 days of D/N Test sold out: Ganguly

Kolkata, Nov 15 (IANS) Tickets for the first three days of the Day/Night Test between India and Bangladesh at the Eden Gardens have been...
- Advertisement -

More Articles Like This